INC Magazine
Editor-in-Chief
Managing Editor
Publishing Control Team
Visualizer
Art & Design Head
Business Development Manager Co-designer
Business Development Execu�ve Marke�ng Manager
Technical Head
Assistant Technical Head
Digital Marke�ng Manager
Assistanr Digital Marke�ng Manager
Research Analyst
Circula�on Manager
Sonal K. Ehsan Jami Alex, Michael
Mary Chars
Anushka Bhosle Shweta Ambilwade
Jone Smith Chirs Philip Maria, Wilson, Mar�na, Alex, Kelvin
Jacob Smile Alina Sege
Jennifer Parker David King
Earl Lewis Scoot Taylor
sales@theincmagazine.com August,
Copyright © 2025 The Inc Magazine
DRIVING INNOVATION & GROWTH IN HEALTHCARE RCM
THE CAREER ODYSSEY OF HH CHEN
The 5 Most Outstanding Leaders in the Healthcare Industry, 2025
An ambitious leader in healthcare revenue cycle management (RCM), HH Chen’s journey is defined by his vision to push the boundaries of what’s possible in RCM through technologies. As the brain and principal architect of CereSoft’s growth, Chen has led and established the company as one of the largest private healthcare RCM companies, focused on sustainable development, collaboration, and adaptability. His commitment to innovation and fearless leadership is shaping the future of RCM and impacting the healthcare landscape.
company maintain its position as a trusted leader in private healthcare revenue cycle management.
Customer-Centric Approach at CereSoft
The CereSoft Journey: A Visionary Perspective
CereSoft’s story is one of ingenuity and perseverance, growing from an ambitious idea to a leader in healthcare revenue cycle management. Founded in 1994, the company has evolved under HH Chen’s visionary leadership, defining excellence in the dynamic healthcare industry.
CereSoft’s early innovation in machine-readable technologies addressed paper-based challenges, streamlining processes and reducing errors. The company’s sustainable growth is rooted in its core cultural principles, including fearless determination, collaboration, and a commitment to sustainable growth. Customer feedback drives product evolution, refining tools that serve value-based care and beyond. Chen’s leadership approach fosters a "fearless and self-assured" team through trust, empowerment, and mentoring.
Early Innovations in Machine-Readable Technologies: Impact
CereSoft’s early innovations in machine-readable technologies enabled the development of systems that convert physical documents into digital formats, ensuring data integrity and reducing errors. This approach simplifies the workflows and sets the stage for integrating automation into traditional processes.
CereSoft built a bridge between legacy systems and modern solutions by emphasizing accuracy, efficiency, and adaptability, establishing itself as a transformative force in revenue cycle management.
Primary Principles for Fostering Sustainable Growth
CereSoft’s growth is rooted in its culture of innovation, adaptability, and collaboration. The company builds a team that values continuous learning and embraces change, navigating industry complexities with agility.
Customer feedback plays a crucial role in CereSoft's innovation process. By gathering and analyzing insights from healthcare providers, the company ensures its products and services address real-world challenges. This feedback informs product refinement and guides the development of new tools, enhancing functionality and strengthening client relationships. CereSoft’s collaborative approach strengthens it as a trusted partner in healthcare transformation, with customer feedback at the forefront of its product evolution strategy.
Chen’s Leadership Approach: Nurturing a Confident Culture
Chen’s leadership approach focuses on empowerment, transparency, and connection by trusting the team to take ownership and take calculated risks. By providing clear expectations and offering consistent support, Chen nurtures an environment where individuals feel capable and confident. Open communication and honest feedback foster trust and alignment. Celebrating successes, learning from challenges, and valuing every team member help maintain a culture where everyone can feel heard and valued. This combination of empowerment, transparency, and connection has been instrumental in shaping a fearless, self-assured team at CereSoft.
Mentoring Future Leaders: Key Focus Areas
CereSoft’s approach to mentoring top performers and future leaders is intentional and caring. One-to-one discussions encourage open sharing of aspirations, doubts, and ideas. Chen offers tailored opportunities, such as leadership, to expand capabilities and instill confidence.
Chen emphasizes self-reflection, empathy, and adaptability, ensuring future leaders are skilled and aligned with the company’s mission.
ensure alignment with both technical and emotional needs.
This experience taught Chen the importance of clarity and consistency in times of change. By explaining the "why" behind a decision and making tangible efforts to ease transitions, Chen fostered trust and rallied the team behind the vision.
Fostering Innovation and Team Alignment
To remain innovative and keep the team aligned and motivated, Chen focuses on prioritizing a culture of curiosity and experimentation. Clear communication and a shared sense of purpose ensure everyone is working on shared goals. Regular strategy sessions and cross-functional meetings promote adaptability and alignment.
Chen strives to make his team members feel empowered and motivated by recognizing individual and collective achievements. Through iterative learning and continuous enhancements, they also inform future strategies, keeping the team ahead of the curve, A sensor-driven growth.
CereSoft’s Response to Value-Based Care
The shift toward value-based care has significantly influenced CereSoft’s approach to developing services and tools. The company has adapted by developing solutions focused on efficiency, transparency, and data-driven insights, aligning financial workflows with clinical results.
CereSoft’s tool leverages advanced analytics, AI, and machine learning to offer actionable insights, supporting strategic decision-making and care delivery. Additionally, the demand for interoperability has grown significantly under value-based care frameworks. To meet this need, CereSoft has prioritized the development of systems that facilitate seamless data exchange across various platforms, enabling healthcare organizations to collaborate more effectively.
Outsourcing allows healthcare organizations to access specialized expertise focused on patient care and to adapt to regulatory changes and market demands. When implemented thoughtfully, automation and outsourcing can empower providers to enhance financial sustainability, improve patient experience, and navigate the complexities of value-based care. A balanced approach prioritizing data security, compliance, and strategic collaboration is vital for success.
Modernizing Healthcare Partnerships
When partnering with hospitals or health systems that are slow to modernize, a thoughtful and collaborative approach is essential. Understanding their unique challenges and priorities helps establish trust and emphasizes alignment with their mission to deliver quality patient care.
Incremental modernization, starting with small, impactful projects, can demonstrate tangible benefits and build confidence in innovation. Education plays a major role, offering insights into how technology can improve operational efficiency, enhance patient results, and ensure compliance.
The Key Insights from HH Chen’s Journey
Chen’s journey highlights several lessons that he wishes he had known earlier. Adaptability and resilience are crucial in today’s fast-paced business environment. Embracing change and staying open to the newest trends is crucial. Building relationships with peers, mentors, and competitors is essential for guidance and innovation.
Entrepreneurs can navigate tough industries and achieve long-term success by focusing on resilience, foresight, and learning through experience. Patience and strategic focus are also required, enabling entrepreneurs to make thoughtful decisions and stay focused on their goals.
Advice for Technologists and Academics
To succeed in complex regulated industries,
compliance and ethics, and focus on problem-solving.
harnessing academic strengths are essential. Strategic communication for vision can help drive notable change.
The Future of RCM and Claims Processing: Role of AI
AI and data intelligence are revolutionizing Revenue Cycle Management (RCM) and claims processing by enhancing efficiency, accuracy, and decision-making. By streamlining processes, providing predictive insights, and supporting strategic decision-making, these technologies are transforming the healthcare landscape.
They empower healthcare organizations to enhance patient experiences, facilitate regulatory compliance, and promote Interoperability, ultimately aligning RCM with value-based care models and ensuring adaptable healthcare systems.
Evolution and Innovative Roadmap
CereSoft prioritizes its next development by analyzing emerging trends, industry needs, and feedback from healthcare providers. The company integrates technologies like AI and advanced analytics to address the most pressing challenges in revenue cycle management. CereSoft aligns its innovation roadmap with regulatory changes and industry complexities, ensuring its solutions remain relevant and impactful. This approach enables the company to drive efficiency and value across the spectrum.
Emerging Technologies in the RCM Space
Chen believes emerging technologies like AI-driven solutions, blockchain, and advanced data analytics will disrupt the RCM space. AI is expected to enhance automation, streamline billing and claims processes, and provide predictive insights for better decision-making. Blockchain could improve transparency, accuracy, and security in transactions. These innovations hold the potential to transform RCM by improving efficiency, accuracy, and adaptability across healthcare systems.
CereSoft’s Exciting Initiative: To Transform Healthcare Systems
CereSoft is excited about its AI-driven solutions that provide deeper data analytics, predictive insights, and enhanced automation. These innovations aim to streamline billing and claims processes, increase accuracy, and empower providers to navigate complexities with ease.
CereSoft’s pipeline is poised to drive notable transformation in revenue cycle management, with scalable solutions tailored to meet the needs of smaller healthcare systems and independent practices.
CereSoft future-proofs its position by embracing a proactive approach, investing in research and development, and integrating emerging trends like AI, blockchain, and advanced cybersecurity measures. The company also cultivates a culture of adaptability, empowering its team to anticipate and respond to challenges with agility. To combat the industry's slow pace of change, the company prioritizes educating its partners, demonstrating the tangible benefits of innovation, and aligning its solutions with regulatory shifts.
Road Ahead
CereSoft plans to leverage cutting-edge technologies to enhance the efficiency and accuracy of revenue cycle management (RCM). The company aims to expand its AI-driven solutions, enabling deeper data analytics, predictive insights, and advanced automation that empower healthcare providers. CereSoft also intends to strengthen partnerships, driving innovation and aligning with evolving regulatory landscapes.
Future-Proofing CereSoft: Chen’s Take on
Mary Tagliaferri Chief Medical Officer | Nektar Therapeutics
An Ardent Leader Setting a New Benchmark in the Biopharmaceutical Industry Mary Tagliaferri
Dr. Mary Tagliaferri, a breast cancer survivor, mother, and amazing business leader, heads Nektar Therapeutics, a global biopharmaceutical company, in pursuit of clinical excellence. She boasts over two decades of professional expertise in pharmaceutical medication development, including substantial regulatory skills in the fields of oncology and women's health.
In the key position of Chief Medical Officer at Nektar, Dr. Tagliaferri directs clinical strategy, clinical operations, biometrics, pharmacovigilance and oversees the company's medical affairs, significant clinical investigator contacts, medical writing and publication tasks. She has provided strategic development leadership for the company's immuno-oncology and immunology portfolio since joining Nektar in January 2015.
Nektar Therapeutics: At a Glance
Nektar Therapeutics is a biopharmaceutical firm with a strong, entirely owned R&D pipeline of experimental drugs in oncology and immunology, as well as a portfolio of authorized partnering medicines.
They plan to start a global Phase 2b clinical trial this year for people with moderate to severe atopic dermatitis (AtD) whose condition cannot be effectively controlled by topical anti-inflammatory
drugs. AtD can have a substantial negative influence on patients' and their families' quality of life because it is a chronic skin condition. Due to the obvious eczematous patches on their skin, patients may experience social shame. Additionally, the severe itching and constant scratching can severely disrupt sleep. With ongoing symptoms and numerous restless nights, AtD can negatively affect emotional health and result in depression.
Rezpegaldesleukin (Rezpeg), a novel chemical from Nektar, is the company's main immunology medication that is currently undergoing clinical testing. It targets the underlying immunological dysregulation by restoring T regulatory cells in both quantity and function to tame the excessive effector T cell response. We think this therapy has the potential to improve the lives of patients since it has a completely different mechanism of action from the atopic dermatitis medications that are now approved.
Rezpeg in AtD recently exhibited early efficacy results that showed greater efficacy than presently approved biological medicines and provided a long-lasting impact for up to 9 months without treatment. Because of these encouraging new data showing remarkable efficacy, safety, and persistence, the company is enthusiastic to move Rezpeg into a Phase 2b trial in patients with moderate to severe atopic dermatitis.
Dr. Tagliaferri highlights both her work in immunology and the significant clinical advancements in oncology. The primary objective for enhancing the effectiveness of cellular treatments has been to improve the function or fitness of CAR T cells. We think their treatment, NKTR-255, could have a wide range of applications to boost cellular therapies, including CAR T cells, TILs, engineered T cell receptor therapies, and NK cell products.
Dr.Tagliaferri’s Roller-coaster Ride
"Much of my inspiration and commitment to finding new and improved therapies for patients is fueled by my own journey with cancer", said Mary Tagliaferri.
Dr. Tagliaferri’s story truly began when, at the young age of 30, she was diagnosed with early-stage breast cancer. She faced major precancerous breast disease in her 40s, which necessitated a bilateral mastectomy. In her 50s, Dr. Tagliaferri was diagnosed with a new type of cancer. She and numerous other patients were forced to come around to new clinical procedures during the COVID pandemic, which made obtaining care more challenging and impersonal.
Having endured long periods of treatment, side effects, and recovery, the heroic physician was reminded over and over of the importance of discovering new cancer medicines, especially ones with low toxicities, so patients can have the highest chances of a cure and the fewest life-disrupting side effects.
Throughout her three decades of experience in drug development, the magnificent woman led clinical research in a broad range of fields, including oncology, immunology, pulmonology, infectious disease, and women’s health.
Prior to Nektar, she co-founded Bionovo, a biotech business specializing in the research and development of cancer and women's health medicines. She also co-founded the Mt. Zion Carol Franc Buck Breast Cancer Translational Research Program in Botanical Medicine and the first traditional Chinese medicine
clinic at the cancer center early in her career at the University of California, San Francisco.
What Makes Dr. Mary Tagliaferri a Healthcare Pioneer?—The
Key Elements
Curiosity, being a quick learner, being extremely flexible to the shifting biopharmaceutical landscape, and attention to the company's goals and purpose are just a few of the qualities that have benefited Dr. Tagliaferri's career advancement. She also places a high priority on ethical behavior, success being acknowledged, receiving constructive criticism, and rolling up her sleeves to get the job done. These principles help put the visionary approach into practice.
The Significance of Diversity and Inclusion
Dr. Tagliaferri works hard to create an inclusive and equitable atmosphere. As the mother of two black children, she has had a personal and distinct perspective on racial discrimination. She has frequently witnessed inaccurate assumptions being made about her children based on the color of their skin. The entire Nektar team upholds a zero-tolerance policy with regard to prejudice, and Dr. Tagliaferri highlighted that the workplace fosters a culture of respect for one another.
Achievements to be Proud of
Dr. Mary Tagliaferri has tremendous professional success with numerous memorable accomplishments. She garnered two honors from the San Francisco Business Times in 2019, including Women Who Lead in Life Sciences and The Most Influential Women in Business. She received the Woman of the Year award from the State of California's Assembly District 14 in 2012 for her dedication to women's health, particularly breast cancer awareness, and for her mentoring of young women in the biotech industry.
Dr. Tagliaferri’s Take on the Gender Pay Gap
I strongly believe in leading by example and providing a roadmap to success. Regarding pay, I serve on the compensation committees for two
publicly-traded companies, RayzeBio and Enzo Biochem, and there are simple and equitable approaches to evaluating fair compensation that address salary, equity allocation, and benefits by using a third-party consultant specializing in compensation to create an objective process for establishing equitable compensation regardless of gender. Leveraging objective data to support pay equality is my strong advice for bringing about meaningful change.
Planning for a Brighter Future Ahead
It would be incredibly satisfying to see Rezpeg approved for the treatment of atopic dermatitis and other autoimmune indications. A significant life achievement would be NKTR-255, a new polymer-conjugated human IL-15, being approved, which would demonstrate the efficacy of a cytokine for the treatment of cancer.
Serving on the Board of Directors for two companies, including as Chairperson for one, Dr. Tagliaferri is looking forward to new opportunities to serve as a Board member for emerging companies in the next few years.
On a personal level, she wishes to continue to be very physically active. As someone who has reaped numerous personal benefits from years of meditation and community building with a network of like-minded people, she relishes the idea of teaching meditation classes.
Parting Words by Dr. Mary Tagliaferri
Keep a good balance of work, rest, and play; keep strong connections to your community of family and friends; and don’t forget that laughter is some of the best medicine.
INNOVATIONS IN HEALTHCARE A GLOBAL PERSPECTIVE ON HEALTH TECHNOLOGY
In recent years, technology has become an integral part of healthcare systems worldwide. Various countries are leveraging advancements in technology to enhance the health and well-being of their citizens. From telemedicine to artificial intelligence (AI), these innovations are transforming how people get help with addiction treatment, boosting immunity and how overall healthcare is delivered, ultimately leading to healthier residents and longer life expectancies.
Telemedicine: Bridging the Gap
Telemedicine has emerged as a vital tool in healthcare, particularly during the COVID-19 pandemic. According to a report by the World Health Organization (WHO), the use of telehealth services increased by over 150% in many countries during the pandemic. This surge allowed patients to consult healthcare professionals from the safety of their homes, reducing the risk of virus transmission.
Dr. Sarah Johnson, a GP in the UK, stated, “Telemedicine has revolutionised the way we approach patient care. It has made healthcare more accessible, especially for those in remote areas.” This shift not only improves access but also enables quicker diagnosis and treatment, leading to better health outcomes.
Artificial Intelligence and Data Analytics
Countries are increasingly employing AI and data analytics to address health issues more effectively. For instance, in the United States, AI algorithms are being used to predict patient outcomes and identify at-risk populations. A study published by Research Gate found that AI-driven predictive analytics could reduce hospital readmission rates by up to 20%.
Furthermore, AI is being utilised in diagnostics. In 2020, researchers at Stanford University developed an AI system that can detect pneumonia in chest X-rays with an accuracy rate of 94%. This technology allows for faster and more accurate diagnoses, enabling healthcare providers to initiate treatment sooner.
Wearable Technology and Health Monitoring
Wearable technology, such as fitness trackers and smartwatches, has gained popularity in many countries. These devices enable individuals to monitor their health metrics, such as heart rate and physical activity levels. A survey conducted by the Pew Research Center revealed that 30% of adults in the US own a fitness tracker, with many citing improved health awareness as a key benefit.
By encouraging individuals to take charge of their health, wearable technology contributes to healthier lifestyles. According to a study published in the Journal of Medical Internet Research, participants who used fitness trackers increased their physical activity by an average of 40%.
E-Health Initiatives and Health Education
Several countries are implementing e-health initiatives to educate residents about health issues and promote preventive care. For example, Australia’s Digital Health Strategy aims to provide citizens with access to online health resources, empowering them to make informed decisions about their health.
Health education through digital platforms has proven effective in managing chronic diseases. A report by the National Health Service (NHS) in the UK indicated that patients who engaged with online health education resources showed a 25% improvement in managing their conditions, leading to fewer hospital visits.
Technology is playing a pivotal role in enhancing the overall health of populations across the globe. By utilizing telemedicine, AI, wearable technology, and e-health initiatives, countries are not only addressing health issues more quickly but also fostering healthier lifestyles among their residents. As these innovations continue to evolve, we can expect further improvements in health outcomes and longevity, ultimately leading to a healthier future for all.
In the words of Dr. Emily Carter, a public health expert, “The integration of technology in healthcare is not just a trend; it is the future of medicine. By embracing these changes, we can ensure that our populations live longer, healthier lives.”
